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cDepartment of Internal Medicine, University of Kentucky College of Medicine, 900 S. Limestone 
Street Suite 303, Lexington, Kentucky 40536, USA
Abstract
Recent studies show a substantial incidence of Pneumocystis jirovecii colonization and infection in 
patients with chronic inflammatory lung conditions. However, little is known about the impact of 
Pneumocystis upon the regulation of pulmonary immunity. We demonstrate here that 
Pneumocystis polarizes macrophages towards an alternatively activated macrophage-like 
phenotype. Genetically engineered mice that lack the ability to signal through IL-4 and IL-13 were 
used to show that Pneumocystis alternative macrophage activation is dependent upon signaling 
through these cytokines. To determine whether Pneumocystis-induced macrophage polarization 
would impact subsequent immune responses, we infected mice with Pneumocystis and then 
challenged them with Pseudomonas aeruginosa 14 days later. In co-infected animals, a higher 
proportion of macrophages in the alveolar and interstitial spaces expressed both classical and 
alternatively activated markers and produced the regulatory cytokines TGFβ and IL-10, as well as 
higher arginase levels than in mice infected with P. aeruginosa alone. Our results suggest that 
Pneumocystis reprograms the overall macrophage repertoire in the lung to that of a more 
alternatively-activated setpoint, thereby altering subsequent immune responses. These data may 
help to explain the association between Pneumocystis infection and decline in pulmonary function.
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1. Introduction
Pneumocystis jiroveci is an opportunistic fungal pathogen that often causes pneumonia in 
immunocompromised patients. Recently it was recognized that colonization with 
Pneumocystis is associated with a decline in pulmonary function in smokers and patients 
with severe forms of chronic obstructive pulmonary disease (COPD) (Morris et al., 2000; 
Morris et al., 2004b; Morris et al., 2008a) as well as cystic fibrosis (CF) (Calderon et al., 
2010; Friaza et al., 2010; Sing et al., 2001). In addition to colonization and infection with 
multiple microorganisms, these patients have the hallmarks of chronic lung diseases (airway 
inflammation, airway remodeling, and parenchymal damage). This creates a complex 
microenvironment that complicates our understanding of the role of microbes during the 
development of pulmonary damage and repair. It is unknown whether the presence of 
Pneumocystis alters the homeostatic set point of immune activation, nor how this influences 
subsequent pulmonary insults.
Macrophages play a key role in the clearance of Pneumocystis infection (Ezekowitz et al., 
1991; Limper et al., 1997; Masur et al., 1978; O’Riordan et al., 1995). They account for the 
majority of inflammatory cells recovered in bronchoalveolar lavage (BAL) samples from 
COPD patients and are localized to sites of alveolar destruction. The influence of specific 
macrophage characteristics on other immune cell types during pulmonary infection with 
Pneumocystis are poorly understood. Macrophages have been described along a continuum 
of gene expression patterns and functional status (Mantovani et al., 2002; Montaner et al., 
1999; Nelms et al., 1999; Stout et al., 2004). In contrast to the classical activation of 
macrophages (CAM) induced by Th1 cytokines to an inflammatory effector cell that utilizes 
reactive oxygen species for pathogen elimination (Mantovani et al., 2002; Munder et al., 
1998), alternatively-activated macrophages (AAM) not only orchestrate inflammation during 
Th2-type responses, but also play a role in the regulation of inflammation and the 
coordination of extracellular matrix protein production responsible for tissue remodeling and 
repair (Gordon, 2003). AAMs demonstrate marked up-regulation of mannose receptor (MR), 
CD23, and arginase 1, the latter of which is thought to be responsible for inhibition of CAM 
responses in mice (Bansal et al., 2003; El Kasmi et al., 2008; Herbert et al., 2004; Herbert et 
al., 2010). The role of alternative macrophage activation during Pneumocystis infection and 
colonization is unknown and represents an opportunity to better understand the role of 
Pneumocystis colonization in patients with chronic lung diseases.
Evidence suggests that alternative macrophage activation plays a role in the pathogenesis of 
COPD and CF and could have significant implications in the evolution of inflammation and 
pulmonary remodeling in this setting (El Kasmi et al., 2008; Pesce et al., 2009a; Pesce et al., 
2009b; Wilson et al., 2009; Wynn et al., 2010). Our previous work found that immune 
responses to acute bacterial pneumonia can be altered by manipulating alternative 
macrophage activation. Induction of an AAM-like phenotype in a mouse model of 
Pseudomonas pulmonary infection causes a blunted neutrophil influx and decreased 
peribronchiolar inflammation (Feola et al., 2010). The induction of arginase 1 expression in 
these mice infected with Pseudomonas, as well as in other models of infection including 
Schistosoma mansoni, appears to be protective through the suppression of excessive 
inflammation (Feola et al., 2010; Pesce et al., 2009a). Although much is known of the 
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function of arginase in the coordination of remodeling and repair, several studies have also 
investigated its role in the inflammatory response to pathogens that elicit both Th1- and Th2-
type responses. With Th1-dominant infections, Arg1 expression counters effective responses 
by suppressing NO production, as shown in mouse models of Mycobacterium species and 
Toxoplasoma gondii infection (El Kasmi et al., 2008). Conversely however, in the Th2-
dominant response to Schistosoma mansoni, macrophage-specific expression of arginase-1 
regulates the pathologic aspects of Th2-driven inflammation and fibrosis (Herbert et al., 
2004; Pesce et al., 2009b).
Here, we demonstrate that Pneumocystis infection induces characteristics of alternative 
macrophage activation both in vitro and in vivo. We also show that the Pneumocystis-
induced AAM phenotype persists and alters the immune response to a secondary bacterial 
challenge. Additional studies in IL-4Rα−/− mice suggest that Pneumocystis-mediated 
macrophage polarization is, to an extent, dependent upon IL-4 and/or IL-13 signaling, 
although this absence does not alter the kinetics of Pneumocystis clearance in these mice. 
These studies provide evidence for immune modulation as a result of colonization or 
infection with Pneumocystis that may influence the progression of pathology associated with 
chronic lung diseases.
2. Materials and Methods
2.1. Mice
Five- to 8-wk-old C57BL/6, BALB/c, and BALB/c-Il4ratCAMSz/J (IL-4Rα−/−) mice were 
obtained from Jackson Laboratories, bred, and maintained at the AALAC accredited 
University of Kentucky Animal Facility. The IL-4Rα−/− mouse is homozygous for the 
Il4ratCAMSz targeted mutation. IL-4Rα is a common chain that is present in IL-4 and IL-13 
receptors and is required for transmitting signals for both cytokines (Kondo et al., 1993; 
Russell et al., 1993). These mice are unable to respond to IL-4/IL-13 to induce alternative 
macrophage activation. Mice were housed in pathogen-free isolation, given food and water 
ad libitum, and transferred to a biosafety housing unit after infection. Pneumocystis was 
maintained in a colony of Rag1−/− mice as a source for all infections. All experimental 
animal studies were approved by the University of Kentucky Institutional Animal Care and 
Use Committee and were conducted in accordance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals.
2.2. Enumeration of inoculated Pneumocystis organisms
To prepare Pneumocystis for inoculation, lungs removed from infected Rag1−/− mice were 
pushed through a stainless steel mesh and collected in HBSS. Debris was removed by 
centrifugation, and aliquots of lung homogenates were spun onto glass slides, fixed with 
methanol, stained using DiffQuik (Siemens, Germany) reagents, and the number of 
Pneumocystis nuclei were counted. To infect mice, animals were anesthetized lightly with 
isoflurane gas, and 105 to 107 Pneumocystis nuclei, depending upon the experiment, were 
injected intratracheally (i.t.) in 100µl of PBS. For detection of Pneumocystis burden, the 
right lung lobes of each animal were excised, minced, and digested in RPMI 1640 
supplemented with 2% fetal calf serum, 1 mg/ml collagenase A, and 50 U/ml DNase. 
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Digested fractions were pushed through mesh screens, and aliquots were spun onto glass 
slides and stained with Diff-Quik for microscopic enumeration. Lung burden is expressed as 
log10 Pneumocystis nuclei per animal with a lower limit of detection of log10 3.23.
2.3. Infection with P. aeruginosa
The clinical mucoid strain P. aeruginosa M57-15, a gift from Anna Van Heeckeren, PhD, 
Case Western University, was used in these experiments. The bacteria were grown in 
trypticase soy broth (TSB) to late log phase or early stationary phase. The method for 
incorporation of the bacteria into agarose beads, essential to induce prolonged infection in 
mice, was adapted from previously described methods (Nacucchio et al., 1984; van 
Heeckeren et al., 2002). P. aeruginosa-laden agarose beads were diluted to achieve an 
inoculum of 1 to 2x105 CFU per 100µl, which is approximately the lethal dose 10 percent 
(LD10). Fourteen days after Pneumocystis inoculation as described above, P. aeruginosa-
laden beads were instilled intratracheally using a blunted 24-gauge curved inoculation 
needle while the animals were under isofluorane anesthesia. To confirm the actual inocula 
given, an aliquot of the bead preparation was homogenized and plated on Pseudomonas 
selection agar immediately after infection and counted after overnight incubation.
Mice were humanely euthanized on day 0 prior to infection with P. aeruginosa and on 
postinfection days 3 and 10. Bronchial alveolar lavage and lung digest samples were 
obtained as described above. An aliquot was plated to assess bacterial burden by manual 
CFU counting on Pseudomonas selection agar. This agar was used to avoid contamination 
from upper airway flora. We have verified that the lavage procedure does not significantly 
affect bacterial counts of homogenized lung tissue.
2.4. Isolation of macrophages from alveolar space and lung interstitium
Mice were humanely euthanized by exsanguination under deep anesthesia. The lungs were 
lavaged with 1ml aliquots of HBSS containing 3mM EDTA. Lungs were then removed and 
digested in medium as discussed above. After removing an aliquot for enumeration of 
Pneumocystis organisms, lung fragments were then filtered and red blood cells lysed in a 
hypotonic solution and analyzed as lung interstitium. Single cell suspensions of lavaged cells 
and lung digest were washed and counted.
2.5. In vitro experiments
Both an immortalized macrophage cell line and primary macrophages were utilized. Primary 
bone marrow and alveolar macrophages were harvested from naïve BALB/c and IL-4Rα−/− 
mice. To obtain alveolar macrophages, lungs were lavaged as described above. Primary bone 
marrow macrophages were harvested after isolation of femurs and tibias by inserting a 26 
gauge needle into the marrow and flushing with RPMI containing 5% FBS and penicillin/
streptomycin. The J774A.1 cell line, an immortalized macrophage cell line obtained from 
adult BALB/c mice, was purchased from ATCC (Manassas, VA) (Ralph et al., 1975). The 
macrophages were plated in 24-well plates at 2x105 cells/well in RPMI (Invitrogen) 
supplemented with 5% FBS, β-mercaptoethanol (500µM), and penicillin/streptomycin 
(10000 Units/ml, 10000µg/ml). Cells were stimulated with IL-4 and IL-13 (10ng/ml) plus 
LPS (50ng/ml), LPS alone, Pneumocystis organisms at a multiplicity of infection (MOI) of 
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10, or media alone. At 4h and 24h post-stimulation timepoints, cells were washed, harvested, 
and counted. Separate aliquots of cells were either stained for flow cytometry or preserved 
for protein or mRNA analyses.
2.6. Flow cytometric analysis of immune cell populations
Lung lavage and lung digest cells were washed in PBS containing 0.1% BSA and 0.02% 
sodium azide and stained with appropriate concentrations of fluorochrome-conjugated 
antibodies specific for murine CD11b, CD11c, Gr-1/Ly6G, MR, CD23, FIZZ-1, or CCR7. 
Antibodies were purchased from eBioscience (San Diego, CA) or BD Biosciences (San Jose, 
CA). Surface expression was determined by multiparameter flow cytometry using a 
FACSCalibur cytofluorimeter (BD Biosciences). For intracellular cytokine staining, 2x106 
cells from each sample were incubated for 4 hours with 50ng/ml PMA and 500ng/ml 
ionomycin, and in the presence of 10µg/ml brefeldin A for the final 2 hours. Cells were 
surface stained for CD11b, CD11c, and GR-1 and fixed in 4% formalin. Subsequently, cells 
were permeabilized in 0.05% saponin, exposed to anti-CD16/32 antibody to block Fc 
binding, and incubated with fluorescently labeled antibodies specific for tumor necrosis 
factor (TNF)-α, transforming growth factor (TGF)-β, and interleukin (IL)-10. Cells were 
washed thoroughly and resuspended in PBS for analysis. Fluorescence characteristics for at 
least 50,000 events per sample were acquired using a BD LSRII Flow Cytometer System 
(BD Biosciences) and analyzed with FlowJo (version 7.5.5, Treestar, Ashland, Oregon). All 
analyses included isotype and single color controls.
2.7. qRT-PCR of AAM gene expression
For Arg1, Fizz1, and Ym1 mRNA analysis, lung digest cell suspensions were collected in 
0.5ml Allprotect stabilization reagent (Qiagen, Valencia, CA), and stored at −80°C until 
analysis. Cells were homogenized on ice, and total RNA was isolated using RNeasy kits 
(Qiagen). mRNA was quantified with an ND-1000 (NanoDrop Technologies, Wilmington, 
DE). Reverse transcriptase reactions were performed with 10ng of mRNA using Taqman 
Reverse Transcriptase kit from Applied Biosystems (Carlsbad, CA). Quantitative real-time 
PCR reactions were performed using 2ng cDNA loaded in 386-well plates using an 
epMotion 5070 Automated Pipetting System (Eppendorf, Hamburg, Germany). qRT-PCR 
reactions were run using TaqMan Gene Expression Assay primers (Mm00657889_m1 
(Ym1); Mm00475988_m1 (Arg1); Mm00445109_m1 (Fizz1) and TaqMan Rodent GAPDH 
Control Reagents) with ABI Taqman Universal PCR Master Mix on a 7500HT Fast Real-
Time PCR System (Applied Biosystems).
2.8. Arginase quantification
Lung digest cell preparation aliquots were pelleted and lysed with buffer containing 10mM 
Tris-HCl, 0.4% (w/v) Triton-X-100, and Roche Mini-tablet Protease Inhibitor Cocktail 
(Mannheim, Germany). Total protein was quantified using the bicinchoninic acid 
colorimetric detection assay (Thermo Fisher Scientific) in cell lysates. The activity of 
intracellular arginase was determined from lung digest cell lysates using the QuantiChrom 
Arginase Assay Kit (BioAssay Systems, Haward, CA), which measures the conversion of 
arginine to urea by arginase. After total protein quantification, 20µl of each sample was 
incubated with arginine buffer at 37°C for 6 hours. The urea detection reagent containing 
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anti-isonitrosopropiophenone was then added, and the optical density was read using a 
490nm filter. Readings were standardized to either total protein or cell number against the 
optical density of each sample’s control.
2.9. Statistical analysis
Differences between experimental groups were determined using 1-way or 2-way analysis of 
variance (ANOVA) where appropriate. Bonferroni’s post hoc test was used when performing 
all pair-wise comparisons, and Dunnett’s post hoc test was used when comparing groups to a 
single control condition. Differences were considered statistically significant when p<0.05. 
Analyses were performed using GraphPad Prism software package (GraphPad Software, 
Inc., La Jolla, CA).
3. Results
3.1. Pneumocystis infection causes changes in murine macrophage characteristics
In the absence of underlying immunosuppression, normal BALB/c mice mount an immune 
response against Pneumocystis, resulting in organism lung burdens that peak by day 8–12, 
with clearance observed by day 21 post-infection (Qureshi et al., 2003b). To determine the 
kinetics of macrophage polarization in these animals, normal BALB/c mice were infected 
intratracheally with 107 Pneumocystis nuclei and followed for 28 days. Clearance kinetics 
similar to those reported earlier were observed here (Qureshi et al., 2003a; Qureshi et al., 
2003b), with a peak of infection on day 11 and clearance by day 21 (Fig. 1A). After a 
transient decrease in arginase production on day 4 post-infection, we consistently observed 
an increase in the amount of arginase present in the lungs at day 11 post-infection, and these 
protein levels remained elevated through day 21 despite Pneumocystis clearance from the 
lungs to below the limit of detection by this timepoint (Fig. 1B). We then compared the 
expression of AAM and CAM surface markers on infiltrating monocytes/macrophage 
populations, designated as CD11b+GR1−, isolated from bronchoalveolar lavage or lung 
digest samples by flow cytometry. For the AAM proteins MR and CD23, expression of each 
was increased by Pneumocystis infection in both the alveolar space (lavage) and interstitium 
(digest) (Fig. 2A and B). Expression of both proteins was significantly increased at day 28 
post-infection on CD11b+GR1− cells in the lung lavage, which was beyond the time at 
which the organisms were cleared. Expression of MR and CD23 on infiltrating macrophages 
in the lung digest samples peaked on days 22 and 11, respectively, and returned to baseline 
levels by day 28 post-infection. Expression of CCR7, used here as a marker of classical 
macrophage activation, peaked at day 4 in the lung lavage, and day 11 in the lung digest. 
Expression was back to baseline levels by day 22 post-infection in both lung compartments. 
Taken together, results presented in Fig. 1 and 2 indicate that the macrophages adopt 
characteristics of alternative activation, particularly in the alveolar space and at a time after 
Pneumocystis has been cleared from the lungs.
3.2. Pneumocystis-mediated polarization towards an AAM phenotype is partially 
dependent upon IL-4Rα
To gain insight into the signaling mechanisms responsible for Pneumocystis-mediated 
macrophage polarization, we utilized IL-4Rα−/− mice, which lack the receptor to transduce 
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IL-4 and IL-13 signaling. IL-4 and IL-13 are cytokines produced by T lymphocytes (among 
others) that polarize macrophages to an alternatively-activated phenotype (Gordon, 2003). 
Primary alveolar macrophages from IL-4Rα−/− and wildtype (WT) animals were stimulated 
with Pneumocystis in vitro and then characterized for arginase expression after 24 hours of 
incubation. While arginase activity increased in both WT and IL-4Rα−/− macrophages 
exposed to Pneumocystis over baseline controls (Fig. 3A), macrophages from IL-4Rα−/− 
mice exhibited a more modest up-regulation of arginase production following Pneumocystis 
exposure compared to the WT and media controls. Arginase expression produced in the cells 
isolated from IL-4Rα−/− mice is possibly occurring through another mechanism, as arginase 
can be up-regulated through stimulation by other means, including IL-10 signaling (Bernard 
et al., 2000; Corraliza et al., 1995; Modolell et al., 1995). This suggests that this response is 
at least partially dependent upon IL-4Rα signaling.
To evaluate whether this response occurs in vivo, we infected WT BALB/c and IL-4Rα−/− 
mice with 107 Pneumocystis nuclei and examined macrophage characteristics at day 7 post-
infection. Similar to previous observations, a robust increase in arginase concentration in 
lung digest preparations was shown in WT animals infected with Pneumocystis in 
comparison to uninfected controls (Fig. 4A). This increase in arginase production was 
attenuated in IL-4Rα−/− mice, although the increase was still significant compared to the 
uninfected group. The arginase activity in infected WT animals was approximately 5 times 
greater than those in the infected knockout group (p<0.05). Similar observations were made 
using gene expression analysis of total lung digest cell preparations. WT mice infected with 
Pneumocystis had robust up-regulation of mRNA expression of Arg1, Fizz1, and Ym1 in 
comparison to uninfected controls, but these responses were absent in IL-4Rα−/− mice (Fig. 
4B). These results suggest that IL-4 and/or IL-13 signaling is necessary for Pneumocystis-
mediated induction of AAM gene expression and arginase activity in vivo.
Next, we examined macrophage phenotype in more depth using flow cytometric analyses of 
AAM marker expression in order to evaluate both resident (CD11c+) and infiltrating 
(CD11b+) subsets on day 7 post-Pneumocystis infection. CD11b+Gr1− and CD11c+Gr1− 
cells isolated from bronchoalveolar lavages and lung digests of Pneumocystis-infected 
animals demonstrated a consistent up-regulation of the AAM marker MR in comparison to 
uninfected controls (Fig. 4C). This held true in both the WT and IL-4Rα−/− strains, and in 
both the CD11b+ (infiltrating) and CD11c+ (resident) subsets. By day 7 post-infection, the 
number of CD11b+ cells expressing the classical macrophage activation marker CCR7 were 
decreased by Pneumocystis infection in both the WT and knockout strains in the alveolar 
space, but no change was observed in the lung digests in either mouse strain. The numbers 
of CD11c+CCR7+ cells in the lung lavage were low at this timepoint, and not significantly 
affected by the infection in either strain of mouse. In the lung digest, there was a significant 
increase in the number of CD11c+ cells expressing CCR7 in the knockout animals (p<0.05), 
due to low expression in the uninfected knockout animals.
Cells from infected animals also exhibited an increase in intracellular staining for IL-10 and 
TGF-β (Fig. 4D). Overall there was a more robust increase in the number of cells producing 
IL-10 in the WT animals. The knockout animals, in general, lacked an increase in 
macrophage production of both IL-10 and TGF-β. Interestingly, the numbers of CD11b+ and 
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CD11c+ cells producing TNF-α were significantly higher in the infected WT animals than in 
the infected IL-4Rα−/− mice (p<0.05). Importantly, the Pneumocystis burden in the lungs of 
infected WT and IL-4Rα−/− mice in each experimental replicate did not differ, as each strain 
similarly cleared the fungal burden from the lungs by day 21 post-infection (Fig. 4E). Taken 
together, these data suggest that AAM induction by Pneumocystis is, in large part, 
dependent upon IL-4Rα signaling, however clearance of the organism is not dependent upon 
it. The AAM protein that is the exception to this in our model is MR. It may be that, due to 
the role of MR in responding to fungal pathogens such as Pneumocystis, its expression is 
regulated by other mechanisms during this response.
3.3. Pneumocystis infection alters macrophage responses to subsequent bacterial 
pneumonia
Our data suggests that Pneumocystis infection causes alterations to macrophage 
programming for a substantial time period. We next set out to determine whether these 
changes could influence the response to a subsequent pulmonary infection. We have 
previously published that alternative macrophage activation can alter pulmonary immune 
responses to extracellular bacterial infection in a mouse model (Feola et al., 2010). To 
determine the impact of Pneumocystis infection upon the immune response to secondary 
bacterial pneumonia, we infected mice with P. aeruginosa incorporated into agarose beads 
14 days after they had been infected with Pneumocystis. We chose this design because our 
macrophage polarization data suggests that there is a prevalence of alternative macrophage 
characteristics at this point (Fig. 2). In response to Pseudomonas infection, an increase in 
lung arginase concentrations in animals co-infected with Pneumocystis was observed at day 
3, with persistence through day 10 post-infection (Fig. 5A), although the differences 
between infected groups were not statistically significant at the latter timepoint. Overall 
numbers of total cells, CD11b+ cells, and CD11c+ cells in the lung digest were similar over 
time among groups. We observed an increase in the number of CD11b+ cells in the alveolar 
space, reflected in a significant increase in CD11b+MR+ cells at the day 0 timepoint, before 
infecting with P. aeruginosa (Fig. 5B). On day 3 post-P. aeruginosa infection, the numbers of 
CD11b+MR+ cells were significantly higher in the lung lavage (p<0.01) and lung digest 
(p<0.01) of the mice who had previously been infected with Pneumocystis. By day 10 post-
infection, MR expression on CD11b+ cells was back to baseline levels in both groups. We 
also observed a simultaneous increase in the classical activation marker CD80 in animals 
that had been dually infected on day 3 post-infection with P. aeruginosa (Fig. 5B). 
Consistent with data from previous figures, and from studies in other disease models, these 
results suggest that overall macrophage populations have increased expression of proteins 
characteristic of both classical and alternative activation (Shirey et al., 2010).
Both CD11b+ and CD11c+ subsets were examined by intracellular cytokine staining on days 
3 and 10 post-P. aeruginosa infection (Fig. 5C). While there was a trend of an increase in the 
number of cells producing the pro-inflammatory cytokine TNF-α in the dually infected 
mice, differences between groups were not statistically significant due to a large amount of 
variability (effect over time p=0.154 by 2-way ANOVA). The number of CD11b+ cells 
producing TGF-β trended towards a significant increase in the dually infected group on both 
day 3 and day 10 post infection. The difference in CD11c+ cell production of TGF-β was 
Deckman et al. Page 8
Immunobiology. Author manuscript; available in PMC 2018 February 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
significantly higher in the dual infection group on day 3, as shown in Fig. 5D. The number 
of cells producing IL-10 was also increased in the mice previously infected with 
Pneumocystis, most notably in the CD11c+ subset. However, this increase was not 
statistically significant. These data confirm that Pneumocystis infection alters the set-point 
of macrophage activation, most notably in the more regulatory cytokines TGF-β and IL-10, 
which lead to an alteration in response to the subsequent bacterial infection. It is important 
to note here that some cells in the CD11c+ subset are likely dendritic cells, which also can 
produce IL-10.
Clearance kinetics are shown for P. aeruginosa pooled across experiments in Fig. 5E. No 
significant differences were found between groups. All animals in all replicates were close 
to having cleared the bacteria from the lungs by day 10, regardless of treatment group. The 
percentage of weight change is also shown for data pooled from these experiments (Fig. 5F). 
While no differences on any individual day were significant, the overall weight curves were 
different between groups (p=0.009, 2-way ANOVA), demonstrating a more severe weight 
loss in the group previously infected with Pneumocystis.
4. Discussion
In this report, we show that Pneumocystis skews the population of macrophages in the lungs 
to acquire an alternatively-activated phenotype. Macrophages from IL-4Rα−/− animals were 
restricted in their ability to up-regulate these markers to the same extent as WT animals, and 
gene expression for the AAM genes FIZZ1, arg1, and Ym1 were virtually non-existent. 
Pneumocystis-induced AAM polarization persisted beyond clearance of the organism, and 
was shown to modulate a subsequent immune response to P. aeruginosa. Our results suggest 
that the presence of Pneumocystis alters the overall pulmonary macrophage population, a 
polarization that requires signaling through the IL-4Rα to reach its full effect, and influences 
subsequent challenges to pulmonary immunity.
Recently there has been increased recognition of Pneumocystis colonization and infection in 
smokers and patients with COPD (Morris et al., 2004a; Morris et al., 2008b; Norris et al., 
2011). Because of the association of Pneumocystis and advanced fibrotic processes that 
occur in these patients, we explored the hypothesis that the organism could influence the 
pulmonary environment through its effect on macrophage activation. COPD is generally 
thought to be a consequence of an abnormal response in the lungs to inhaled toxic particles 
and gases, including cigarette smoke (Hogg et al., 2009). While all smokers display low 
level inflammation in the lungs, a small subset of patients experience exacerbated responses 
to environmental stimuli resulting in an amplified inflammatory response and a large scale 
remodeling process that results in the lung lesions and airway obstruction that are 
characteristic of COPD (Hogg et al., 1994; Wright et al., 1984). Indeed, studies indicate that 
acute exacerbations of COPD are attributed to viruses, Mycoplasma, and other infectious 
entities (Seemungal et al., 2001; Smith et al., 1980). A more recent report analyzing the gene 
expression of 18 subjects with COPD who were colonized with Pneumocystis compared to a 
group of 193 subjects who were not colonized, demonstrated that colonized patients had 
upregulated IFNγ and other genes predominantly associated with Th1-polarized T 
lymphocytes (Fitzpatrick et al., 2014). Our data suggests that the presence of Pneumocystis 
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in these patients may cause modulation of the host immune response in the lungs, thereby 
altering inflammation, airway remodeling, or both.
Alveolar macrophages play a critical role in the uptake and degradation of Pneumocystis 
(Ezekowitz et al., 1991; Limper et al., 1997; Masur et al., 1978; O’Riordan et al., 1995). The 
heterogeneous nature of the macrophage lineage lends difficulty to phenotypic and 
functional characterization. In the first two weeks following Pneumocystis infection, 
investigators have observed a greater number of IL-4 secreting CD4+ T cells in comparison 
to CD4+ T cells secreting IFNγ (Nelson et al., 2011; Shellito et al., 2000). Similarly other 
Th2 cytokines, IL-5 and IL-13, are elevated in the BAL between days 3 and 14 after 
infection with Pneumocystis (Meissner et al., 2005; Nelson et al., 2011), and this 
corresponds with robust levels of IL-10 produced early following infection (Meissner et al., 
2005). Elevated levels of these cytokines suggest that Pneumocystis infection induces an 
environment that is favorable to elicit generation of AAM. Additionally, a recent study of 
immune modulation using sulfasalazine demonstrates that this anti-inflammatory agent 
increases Th2 and AAM polarization, which corresponds with an increase in phagocytosis 
and clearance of Pneumocystis (Wang et al., 2010). Our data supports these studies, showing 
that Pneumocystis induces an AAM phenotype within 4 hours of exposure in culture and 
within 4 days in vivo. It is possible that polarization towards this phenotype comes at the 
cost of an alteration in pulmonary immunity that can, at the very least, last for several days.
A study by Nelson et al. indicated that AAM polarization results in an enhanced clearance of 
Pneumocystis (Nelson et al., 2011). In mice deficient in the myeloid Src-family tyrosine 
kinases Hck, Fgr, and Lyn (Src triple knockout (TKO)), they report that the enhanced 
clearance of Pneumocystis from the lungs (Nelson et al., 2009) is associated with this 
strain’s heightened AAM polarization (Nelson et al., 2011). The Src TKO mice displayed 
alveolar macrophages with enhanced production of FIZZ-1 and arginase 1, along with the 
AAM-associated chemokines CCL17, CCL22, and IL-33. A member of the IL-1 family, 
IL-33 acts in concert with IL-13 signaling through IL-4Rα to further up-regulate arginase 1, 
Ym1, and MR expression on macrophages during airway inflammation (Kurowska-
Stolarska et al., 2009). In addition, they demonstrated that treatment with exogenous IL-33 
in normal C57Bl/6 mice results in up-regulation of AAM-markers in mice infected with 
Pneumocystis, and enhanced the phagocytosis of the organism in vitro and its clearance 
from the lungs in vivo (Nelson et al., 2011). These data support the notion that alternative 
macrophage activation is likely playing a functional role in the response and clearance of 
Pneumocystis.
In the current study, our work focuses instead on the effects of the organism upon 
macrophage polarization during a normal response. While Nelson et. al. demonstrated 
dramatic increases in AAM polarization in the experimental mouse models, their control 
animals also exhibited moderate up-regulation of AAM-associated proteins, including 
arginase and FIZZ-1 (Nelson et al., 2011). Comparing across studies, it appears that the 
production of these proteins occurred to a higher degree on day 7 post-infection in the 
BALB/c mice utilized in our work, as compared to the control strain utilized in their work 
(C57Bl/6). This distinction may lie in the phenotypic differences associated with these mice 
with regards to their biases in T cell polarization, with BALB/c mice more adept at Th2-type 
Deckman et al. Page 10
Immunobiology. Author manuscript; available in PMC 2018 February 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
responses. Indeed, response to Pneumocystis includes both Th1 and Th2 subsets, with the 
organism inducing a higher number of T cells to produce IL-4 than IFNγ in a normal 
response (Shellito et al., 2000). A recent study from this group showed that Stat4−/− mice on 
a C57Bl/6 background controlled Pneumocystis growth better than Stat4−/− mice on a 
BALB/c background, which did not exhibit an AAM response (Myers et al., 2013). The 
Nelson study additionally shows no difference in the production of IL-4 or IL-13 in the Src 
TKO mice as compared to the normal control mice (Nelson et al., 2011), a finding that is 
supported by our results that show alternative macrophage polarization to be achieved in 
response to Pneumocystis infection, albeit to a lesser degree, in mice that lack functional 
signaling through the IL-4 and IL-13 receptors.
A recent study by Zhang et al. demonstrates that mice lacking in either CAM or AAM 
responses still possess the ability to clear Pneumocystis (Zhang et al., 2015). By crossing 
IFNγR−/− mice or IL4rα−/− mice to RAG2−/− animals, and then providing WT T cells by 
adoptive transfer, they demonstrated that in the setting of immune reconstitution 
inflammatory syndrome (IRIS), neither CAM or AAM were required for the clearance of 
Pneumocystis. However, while all strains were able to clear the organism, mice that lacked a 
CAM response (RAG2−/−/ IFNγR−/−) had increased Pneumocystis-related 
immunopathologies (Zhang et al., 2015). Our results correspond with theirs in that the lack 
of signaling through the IL4rα to restrict AAM responses did not impact the clearance 
kinetics of the organism. There are important differences between studies, as our mice also 
lack IL4rα on T cells, and in the Zhang study the mice were undergoing immune 
reconstitution, which can in itself cause immunopathology (Bonham et al., 2008). Key 
elements to the response in the mice that lacked IFNγR included impaired CD8+ T cell 
regulatory function and elevated concentrations of IFNγ (Zhang et al., 2015). Indeed, these 
results support that there is a complex balance of macrophage and T cell phenotypic 
responses needed in order to produce an optimal situation of organism clearance and limited 
pulmonary pathology.
Our results that show Pneumocystis infection alters the subsequent response to infection 
with the extracellular Gram-negative bacterial pathogen P. aeruginosa are of significant 
importance. Our previous studies demonstrate that treatment of mice with azithromycin, an 
azalide antimicrobial agent that was demonstrated to induce alternative macrophage 
activation in vitro (Murphy et al., 2008), increases in AAM properties by day 7 post-
infection (including a significantly higher production of arginase) led to a decrease in 
mortality and blunted peribronchiolar inflammation in C57Bl/6 mice infected with P. 
aeruginosa (Feola et al., 2010). Therefore, because Pneumocystis can induce prolonged 
alterations in the polarization set-point of alveolar and interstitial macrophages, subsequent 
responses may be altered, leading to an impact on the pathology of chronic inflammatory 
lung conditions. It is possible that AAM could function to control exaggerated aspects of 
immune responses that accompany these conditions through a variety of mechanisms. These 
include direct suppression of CAM-driven inflammatory processes, control of neutrophil 
recruitment, or suppression of T lymphocyte responses (Kahnert et al., 2006; Katakura et al., 
2004; Muller et al., 2007; Weber et al., 2007; Weng et al., 2007).
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The robust up-regulation of arginase expression and activity following exposure to 
Pneumocystis warrants investigation of the role of this mediator during infection. While 
arginase-1 is known primarily for its role in the coordination of extracellular matrix protein 
production that can result in pulmonary remodeling, it also is involved in limiting 
inflammation. El Kasmi and colleagues demonstrated that in intracellular infection models 
in mice lacking arginase-1 expression, NO production is enhanced, resulting in reduced 
bacterial burdens and lower morbidity to both Mycobacterium species and Toxoplasma 
gondii (El Kasmi et al., 2008). In contrast to these findings, macrophage-specific expression 
of arginase-1 has been shown to regulate the aspects of Th2-driven pathologies such as 
infection with S. mansoni (Herbert et al., 2010; Pesce et al., 2009a). Mice with macrophages 
that lack Arg1 succumb to the associated Th2-driven pathology in this model of infection 
(Herbert et al., 2010). In another model, AAMs were required to limit inflammatory 
pathology associated with RSV infection in mice (Shirey et al., 2010). Studies showed that 
TLR4-mediated RSV-associated Th1-type inflammatory cytokine production was regulated 
by AAM. In addition to cytokine production, these investigators showed that RSV-infected 
IL-4rα−/− mice, which lack substantial arginase-1 expression and blunted AAM responses, 
displayed increased peribronchiolar inflammation (Shirey et al., 2010). These studies 
demonstrate the detrimental consequences that can occur in the absence of AAM effectors.
While the production of arginase was blunted in alveolar macrophages isolated from 
IL-4rα−/− mice, and expression of mRNA for the AAM-associated genes arg1, FIZZ-1, and 
Ym1 were very low in these animals 7 days after being infected with Pneumocystis, arginase 
protein expression was still detected, albeit at a lower level, both in vitro and in vivo. In light 
of the fact that Pneumocystis burdens were not affected in the IL-4rα−/− mice, it is possible 
that the lower degree of alternative macrophage activation and expression of the associated 
effector proteins is enough to elicit the clearance of Pneumocystis. Importantly, the deletion 
of IL-4rα on T cells could also be contributing to the reduction in arginase activation and 
macrophage activation (Dewals et al., 2009). This will be the subject of future investigations.
Overall, our data suggests that the immune consequences of exposure to Pneumocystis may 
not be as innocuous in immunocompetent hosts as once thought. Our studies demonstrate 
that Pneumocystis has the capability to polarize primary macrophages towards an 
alternatively-activated phenotype in an IL-4Rα-dependent manner. This phenomenon occurs 
in a way that can influence subsequent infections and pulmonary insults. The extended 
kinetics of this phenomenon warrants further examination and provides impetus for further 
exploration Pneumocystis-mediated immunomodulation within the lungs of both healthy and 
diseased patients.
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Abbreviations
COPD chronic obstructive pulmonary disease
CF cystic fibrosis
CAM classically activated macrophage
AAM alternatively activated macrophage
BAL bronchoalveolar lavage
MR mannose receptor
CFU colony forming unit
TSB trypticase soy broth
EDTA ethylenediaminetetraacetic acid
MOI multiplicity of infection
FBS fetal bovine serum
ANOVA analysis of variance
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FIG 1. 
Pneumocystis murina infection up-regulates production of arginase in vivo. BALB/c mice 
were infected with 1x107 Pneumocystis (PC) organisms by intratrachael instillation on day 0 
and euthanized at post-infection time points. (A) Pneumocystis burden was assessed over 
time post-infection by microscopically counting organisms in lung digest preparations. (B) 
Arginase activity in lung digest preparations was determined by measurement of the 
conversion of arginine into urea and standardized to total protein.
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FIG 2. 
Pneumocystis murina infection up-regulates the surface protein expression of alternative 
macrophage activation markers in vivo. Cells isolated from bronchoalveolar lavage (A) and 
lung digest (B) preparations from BALB/c mice isolated over time post-infection were 
enumerated and stained for cell surface expression of macrophage proteins and analyzed by 
flow cytometry. After gating out lymphocytes and dead cells by forward and side scatter 
characteristics, the number of cells within the CD11b+GR1− gate that exhibited up-
regulation of MR, CCR7, and CD23 as compared to unstained controls were reported over 
time for each compartment. All graphs display mean ± SD for 3–4 mice per group per 
timepoint, and results are representative of 2 experimental replicates. Values were compared 
using 1-way ANOVA and Dunnett’s post-hoc analysis comparing means to that of an 
uninfected control group. Statistically significant differences between treatment groups 
indicated for P < 0.05 (*).
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FIG 3. 
Pneumocystis induces arginase expression in vitro in a partially IL-4Rα-dependent manner. 
Primary alveolar macrophages from BALB/c or IL-4Rα−/− mice were cultured in 
quadruplicate in the presence of Pneumocystis (PC) organisms (MOI=10), IL-4/13+LPS, or 
media only and harvested after 24 hours. Cell lysates were collected and assayed for 
arginase activity as determined by measurement of the conversion of arginine into urea and 
standardized to total protein. Data is presented as fold increase compared to unstained 
controls for each cell type among CD11c+ cells. Means ± standard deviation are presented 
and are representative of 3 separate experiments. Statistically significant differences between 
treatment groups are denoted as follows: *, P < 0.05 and **, P < 0.01 as analyzed one-way 
ANOVA and Bonferroni post test. Asterisks atop of bars indicate comparison to media 
control condition, with differences between Pneumocystis and IL-4/13 treatments denoted 
by brackets.
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FIG 4. 
Pneumocystis infection induces an AAM phenotype in vivo in an IL-4Rα-dependent 
manner. Wildtype BALB/c and IL-4Rα−/− mice were infected with 1x107 Pneumocystis 
(PC) nuclei by i.t. instillation and euthanized at 7 days post-infection. Cells were isolated 
from the alveolar space via lung lavage, and subsequently whole lungs were digested to 
create single cell suspensions. (A) Arginase activity in lung digest was determined by 
measurement of the conversion of arginine into urea and standardized to total protein. (B) 
mRNA was isolated from lung digest cells and reverse transcribed to cDNA. Gene 
expression was quantified using qPCR to determine gene expression levels of Arg1, Fizz1, 
and Ym1 genes. qPCR data was normalized to values generated in wildtype uninfected 
animals and expressed as fold increase over controls. (C) Cells isolated from lung lavage and 
lung digest samples were stained for surface expression of CD11b, CD11c, Gr1, MR, and 
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CCR7 and analyzed by flow cytometry. Cells that were CD11b+Gr1− and CD11c+Gr1− were 
gated upon, and the numbers of cells in each subset expressing CCR7 or MR were 
determined in both the lung lavage and lung digest samples. (D) The number of 
CD11c+Gr1− (left) and CD11b+Gr1− (right) cells producing IL-10, TGFβ, and TNFα were 
measured by intracellular cytokine staining and flow cytometry. Lung digest preparations 
were incubated with PMA, ionomycin, and brefeldin A as described and surface stained for 
CD11b, CD11c, and Gr1. Following fixation they were subsequently stained for intracellular 
up-regulation of TNFα, TGFβ, and IL-10. (E) Kinetics of PC clearance over time post 
infection, expressed as PC nuclei microscopically counted in lung digest samples. Mean ± 
standard deviations are reported for groups of 4 mice per strain, and are representative of 3 
experimental replicates. Statistically significant differences between treatment groups at 
each timepoint are denoted as follows: *, P < 0.05 by one-way ANOVA and Bonferroni post 
test. Asterisk above bar represent difference compared to uninfected controls for each strain, 
and asterisk above connecting line represents difference between knockout and WT strains.
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FIG 5. 
Pneumocystis infection alters macrophage responses to subsequent Pseudomonas aeruginosa 
infection. Normal C57Bl/6 mice were infected with 1x107 Pneumocystis (PC) nuclei (or 
sham infection) by intratrachael (i.t.) instillation and then challenged with 2x105 CFU P. 
aeruginosa (PA)-laden agarose beads it. 14 days later and euthanized at subsequent 
timepoints. Cells were isolated from the alveolar space via lung lavage, and whole lungs 
were digested to create single cell suspensions. (A) Arginase activity in lung digest was 
determined by measurement of the conversion of arginine into urea and standardized to total 
protein. (B) Cells isolated from lung lavage and lung digest samples were identified as 
CD11b+ and stained for MR and CD80 protein expression and analyzed by flow cytometry. 
(C, D) The number of CD11b+CD11c− (panel C) and CD11b− CD11c+ (panel D) cells 
producing TNFα, TGFβ, and IL-10 were measured by intracellular cytokine staining and 
flow cytometry. Lung digest preparations were incubated with PMA, ionomycin, and 
brefeldin A as described and surface stained for CD11b and CD11c. Following fixation they 
were stained for intracellular up-regulation of TNFα, TGFβ, and IL-10. (E, F) P. aeruginosa 
clearance kinetics and mouse weights are shown over time for data pooled from all 
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experimental replicates. Means ± standard deviations (or SEM for P. aeruginosa CFU 
values) are reported for groups of 3–4 mice per timepoint per condition (or pooled as noted), 
and are representative of 2 experimental replicates. Statistically significant differences 
between treatment groups at each timepoint are denoted as follows: *, P < 0.05; **, P < 0.01 
by two-way ANOVA and Bonferroni post test.
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